Phase 1 Evaluation Comparing Two Tau PET Radiotracers, [18F]PI-2620 and [18F]GTP1, in the Brain of Patients With Prodromal or Mild Alzheimer's Disease
Latest Information Update: 13 Jul 2023
At a glance
- Drugs Florbetapir F 18 (Primary) ; Florquinitau F18 (Primary) ; PI 2620 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Diagnostic use
- Sponsors Genentech
- 11 Jul 2023 Status changed from recruiting to completed.
- 23 Nov 2022 Planned End Date changed from 30 Oct 2022 to 31 Jul 2023.
- 23 Nov 2022 Planned primary completion date changed from 30 Oct 2022 to 31 Jul 2023.